---
document_datetime: 2026-02-20 15:05:46
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/teizeild-epar-all-authorised-presentations_en.pdf
document_name: teizeild-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.9355258
conversion_datetime: 2026-02-21 12:21:12.079693
docling_version:
  docling-serve: 1.13.0
  docling-jobkit: 1.11.0
  docling: 2.74.0
  docling-core: 2.65.1
  docling-ibm-models: 3.11.0
  docling-parse: 5.3.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.3-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented) name   | Strength   | Pharmaceutical Form                   | Route of Administration   | Immediate Packaging   | Content (concentration)   | Pack size   |
|------------------|-------------------|------------|---------------------------------------|---------------------------|-----------------------|---------------------------|-------------|
| EU/1/25/1998/001 | Teizeild          | 1 mg/ml    | Concentrate for solution for infusion | Intravenous use           | vial (glass)          | 2 ml                      | 1 vial      |
| EU/1/25/1998/002 | Teizeild          | 1 mg/ml    | Concentrate for solution for infusion | Intravenous use           | vial (glass)          | 2 ml                      | 10 vials    |
| EU/1/25/1998/003 | Teizeild          | 1 mg/ml    | Concentrate for solution for infusion | Intravenous use           | vial (glass)          | 2 ml                      | 14 vials    |